William R. Jarnagin

72.3k total citations · 9 hit papers
638 papers, 39.1k citations indexed

About

William R. Jarnagin is a scholar working on Oncology, Surgery and Hepatology. According to data from OpenAlex, William R. Jarnagin has authored 638 papers receiving a total of 39.1k indexed citations (citations by other indexed papers that have themselves been cited), including 400 papers in Oncology, 374 papers in Surgery and 270 papers in Hepatology. Recurrent topics in William R. Jarnagin's work include Cholangiocarcinoma and Gallbladder Cancer Studies (262 papers), Hepatocellular Carcinoma Treatment and Prognosis (258 papers) and Pancreatic and Hepatic Oncology Research (244 papers). William R. Jarnagin is often cited by papers focused on Cholangiocarcinoma and Gallbladder Cancer Studies (262 papers), Hepatocellular Carcinoma Treatment and Prognosis (258 papers) and Pancreatic and Hepatic Oncology Research (244 papers). William R. Jarnagin collaborates with scholars based in United States, Netherlands and Canada. William R. Jarnagin's co-authors include Yuman Fong, Ronald P. DeMatteo, Leslie H. Blumgart, Mithat Gönen, Peter J. Allen, Michael I. D’Angelica, Michael I. D’Angelica, T. Peter Kingham, Murray F. Brennan and Nancy E. Kemeny and has published in prestigious journals such as New England Journal of Medicine, Nucleic Acids Research and Journal of Clinical Investigation.

In The Last Decade

William R. Jarnagin

610 papers receiving 38.4k citations

Hit Papers

Improvement in perioperat... 1999 2026 2008 2017 2002 2002 2001 2007 2008 400 800 1.2k
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. Improvement in perioperative outcome after hepatic resection: analysis of 1,803 consecutive cases over the past decade.
    2002 1.2k citations William R. Jarnagin, Mithat Gönen et al. profile →
  2. Improvement in Perioperative Outcome After Hepatic Resection
    2002 1.0k citations William R. Jarnagin, Mithat Gönen et al. Annals of Surgery profile →
  3. Staging, Resectability, and Outcome in 225 Patients With Hilar Cholangiocarcinoma
    2001 982 citations William R. Jarnagin, Yuman Fong et al. Annals of Surgery profile →
  4. Actual 10-Year Survival After Resection of Colorectal Liver Metastases Defines Cure
    2007 884 citations William R. Jarnagin, Ronald P. DeMatteo et al. Journal of Clinical Oncology profile →
  5. Intrahepatic Cholangiocarcinoma
    2008 646 citations Mithat Gönen, David S. Klimstra et al. Annals of Surgery profile →
  6. An Analysis of 412 Cases of Hepatocellular Carcinoma at a Western Center
    1999 641 citations Yuman Fong, William R. Jarnagin et al. Annals of Surgery profile →
  7. Comprehensive Molecular Profiling of Intrahepatic and Extrahepatic Cholangiocarcinomas: Potential Targets for Intervention
    2018 369 citations Maeve A. Lowery, Ryan Ptashkin et al. Clinical Cancer Research profile →
  8. Gallbladder Cancer: expert consensus statement
    2015 297 citations William R. Jarnagin et al. profile →
  9. Randomized Trial of Hepatic Artery Embolization for Hepatocellular Carcinoma Using Doxorubicin-Eluting Microspheres Compared With Embolization With Microspheres Alone
    2016 271 citations Richard Kinh Gian, Mithat Gönen et al. Journal of Clinical Oncology profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
William R. Jarnagin United States 109 22.7k 22.0k 16.3k 13.1k 6.4k 638 39.1k
Ronald P. DeMatteo United States 113 23.6k 1.0× 19.4k 0.9× 13.2k 0.8× 19.3k 1.5× 5.7k 0.9× 541 46.4k
Jean‐Nicolas Vauthey United States 99 21.7k 1.0× 25.8k 1.2× 19.5k 1.2× 12.3k 0.9× 12.0k 1.9× 516 45.7k
Michael A. Choti United States 89 12.4k 0.5× 17.1k 0.8× 7.4k 0.5× 8.6k 0.7× 5.2k 0.8× 309 29.0k
Leslie H. Blumgart United States 99 22.1k 1.0× 18.9k 0.9× 17.3k 1.1× 12.8k 1.0× 5.7k 0.9× 456 35.8k
Masatoshi Makuuchi Japan 97 25.3k 1.1× 11.8k 0.5× 28.1k 1.7× 9.6k 0.7× 13.2k 2.1× 782 48.1k
Michel Ducreux France 91 11.8k 0.5× 26.0k 1.2× 8.7k 0.5× 10.7k 0.8× 8.2k 1.3× 628 38.9k
Richard D. Schulick United States 86 17.3k 0.8× 19.7k 0.9× 4.6k 0.3× 10.6k 0.8× 6.1k 0.9× 347 32.7k
Norihiro Kokudo Japan 80 12.5k 0.6× 7.3k 0.3× 16.4k 1.0× 5.8k 0.4× 7.2k 1.1× 727 26.0k
Jacques Belghiti France 99 17.0k 0.7× 9.7k 0.4× 18.2k 1.1× 6.2k 0.5× 10.9k 1.7× 522 32.2k
Gregory Y. Lauwers United States 88 13.6k 0.6× 11.2k 0.5× 5.2k 0.3× 7.2k 0.5× 6.1k 0.9× 448 28.5k

Countries citing papers authored by William R. Jarnagin

Since Specialization
Citations

This map shows the geographic impact of William R. Jarnagin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by William R. Jarnagin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites William R. Jarnagin more than expected).

Fields of papers citing papers by William R. Jarnagin

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by William R. Jarnagin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by William R. Jarnagin. The network helps show where William R. Jarnagin may publish in the future.

Co-authorship network of co-authors of William R. Jarnagin

This figure shows the co-authorship network connecting the top 25 collaborators of William R. Jarnagin. A scholar is included among the top collaborators of William R. Jarnagin based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with William R. Jarnagin. William R. Jarnagin is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Blair, Alex B., Joshua S. Jolissaint, Deshka S. Foster, et al.. (2025). Outcomes in Locally Advanced Pancreatic Cancer After Induction Ablative Radiation Therapy and Resection. Annals of Surgical Oncology. 32(6). 4108–4116.
2.
Gagnière, Johan, Abhishek Midya, Rikiya Yamashita, et al.. (2025). Postoperative Pancreatic Fistula After Pancreatoduodenectomy. Annals of Surgery.
3.
Kingham, T. Peter, et al.. (2024). The Image-to-Physical Liver Registration Sparse Data Challenge: comparison of state-of-the-art using a common dataset. Journal of Medical Imaging. 11(1). 15001–15001. 8 indexed citations
4.
Gönen, Mithat, Manon C.W. Spaander, Eileen M. O’Reilly, et al.. (2024). Survival of Patients with Resected Microsatellite Instability-High, Mismatch Repair Deficient, and Lynch Syndrome-Associated Pancreatic Ductal Adenocarcinomas. Annals of Surgical Oncology. 32(5). 3568–3577.
5.
Jarnagin, William R., Ghassan K. Abou‐Alfa, James J. Harding, et al.. (2023). Non-Surgical Locoregional Therapies Alone or in Combination with Systemic Therapy in Patients with Hepatocellular Carcinoma. Cancers. 15(6). 1748–1748. 5 indexed citations
6.
Buettner, Stefan, Joris I. Erdmann, Johann Pratschke, et al.. (2023). Multivariable prediction model for both 90-day mortality and long-term survival for individual patients with perihilar cholangiocarcinoma: does the predicted survival justify the surgical risk?. British journal of surgery. 110(5). 599–605. 17 indexed citations
7.
Saadat, Lily V., Elizabeth Schofield, Michael Curry, et al.. (2023). Treatment Patterns and Outcomes in Pancreatic Cancer: A Comparative Analysis of Ontario and the USA. Annals of Surgical Oncology. 31(1). 58–65. 4 indexed citations
8.
Keane, Fergus, Fiyinfolu Balogun, Catherine O’Connor, et al.. (2023). Adjuvant modified FOLFIRINOX (mFFX) for resected pancreatic cancer (PDAC): Real world outcomes (RWO).. Journal of Clinical Oncology. 41(4_suppl). 685–685. 1 indexed citations
9.
10.
Olthof, Pim B., Matteo Cescon, Alfredo Guglielmi, et al.. (2021). Actual 10-Year Survival after Resection of Perihilar Cholangiocarcinoma: What Factors Preclude a Chance for Cure?. Cancers. 13(24). 6260–6260. 11 indexed citations
11.
Chakraborty, Saptarshi, Brett L. Ecker, Kenneth Seier, et al.. (2021). Genome-Derived Classification Signature for Ampullary Adenocarcinoma to Improve Clinical Cancer Care. Clinical Cancer Research. 27(21). 5891–5899. 12 indexed citations
12.
Soares, Kevin C. & William R. Jarnagin. (2021). The Landmark Series: Hilar Cholangiocarcinoma. Annals of Surgical Oncology. 28(8). 4158–4170. 35 indexed citations
13.
Höppener, Diederik J., Boris Galjart, Pieter M. H. Nierop, et al.. (2021). Histopathological Growth Patterns and Survival After Resection of Colorectal Liver Metastasis: An External Validation Study. JNCI Cancer Spectrum. 5(3). 32 indexed citations
14.
Olthof, Pim B., Luca Aldrighetti, Ruslan Alikhanov, et al.. (2020). Portal Vein Embolization is Associated with Reduced Liver Failure and Mortality in High-Risk Resections for Perihilar Cholangiocarcinoma. Annals of Surgical Oncology. 27(7). 2311–2318. 43 indexed citations
15.
Margonis, Georgios Antonios, Kazunari Sasaki, Sepideh Gholami, et al.. (2018). Genetic And Morphological Evaluation (GAME) score for patients with colorectal liver metastases. British journal of surgery. 105(9). 1210–1220. 111 indexed citations
16.
Lowery, Maeve A., Ryan Ptashkin, Emmet Jordan, et al.. (2018). Comprehensive Molecular Profiling of Intrahepatic and Extrahepatic Cholangiocarcinomas: Potential Targets for Intervention. Clinical Cancer Research. 24(17). 4154–4161. 369 indexed citations breakdown →
17.
Pak, Linda M., Jayasree Chakraborty, Mithat Gönen, et al.. (2018). Quantitative Imaging Features and Postoperative Hepatic Insufficiency: A Multi-Institutional Expanded Cohort. Journal of the American College of Surgeons. 226(5). 835–843. 8 indexed citations
18.
Balachandran, Vinod P., Arshi Arora, Mithat Gönen, et al.. (2016). A Validated Prognostic Multigene Expression Assay for Overall Survival in Resected Colorectal Cancer Liver Metastases. Clinical Cancer Research. 22(10). 2575–2582. 29 indexed citations
19.
Lee, Ser Yee, Brian K. P. Goh, Eran Sadot, et al.. (2016). Surgical Strategy and Outcomes in Duodenal Gastrointestinal Stromal Tumor. Annals of Surgical Oncology. 24(1). 202–210. 40 indexed citations
20.
Turcotte, Simon, Steven C. Katz, Jinru Shia, et al.. (2014). Tumor MHC Class I Expression Improves the Prognostic Value of T-cell Density in Resected Colorectal Liver Metastases. Cancer Immunology Research. 2(6). 530–537. 36 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Ronald P. DeMatteo Breakdown of academic impact, for papers by Jean‐Nicolas Vauthey Breakdown of academic impact, for papers by Michael A. Choti Breakdown of academic impact, for papers by Leslie H. Blumgart Breakdown of academic impact, for papers by Masatoshi Makuuchi Breakdown of academic impact, for papers by Michel Ducreux Breakdown of academic impact, for papers by Richard D. Schulick Breakdown of academic impact, for papers by Norihiro Kokudo Breakdown of academic impact, for papers by Jacques Belghiti Breakdown of academic impact, for papers by Gregory Y. Lauwers
Rankless by CCL
2026